Banque Cantonale Vaudoise’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-400
Closed -$7K 1095
2023
Q4
$7K Sell
400
-10,000
-96% -$157K ﹤0.01% 971
2023
Q3
$81K Buy
10,400
+8,000
+333% +$43.3K ﹤0.01% 880
2023
Q2
$12K Buy
+2,400
New +$12.2K ﹤0.01% 1109
2023
Q1
Sell
-2,400
Closed -$8K 1235
2022
Q4
$8K Hold
2,400
﹤0.01% 1124
2022
Q3
$12K Hold
2,400
﹤0.01% 1145
2022
Q2
$14K Hold
2,400
﹤0.01% 1161
2022
Q1
$17K Hold
2,400
﹤0.01% 1169
2021
Q4
$31K Buy
2,400
+1,000
+71% +$16.5K ﹤0.01% 1141
2021
Q3
$32K Sell
1,400
-250
-15% -$7.44K ﹤0.01% 1107
2021
Q2
$73K Buy
1,650
+600
+57% +$33.4K ﹤0.01% 1005
2021
Q1
$76K Sell
1,050
-150
-13% -$10.7K ﹤0.01% 953
2020
Q4
$51K Buy
+1,200
New +$53.7K ﹤0.01% 939

Banque Cantonale Vaudoise's ORTX Position: Q1 2024 in Review

Banque Cantonale Vaudoise sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 400 shares — an estimated $7K sold.

Banque Cantonale Vaudoise first reported a position in ORTX in Q4 2020 and held it in 12 quarters. The position peaked at $81K in Q3 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Banque Cantonale Vaudoise reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 400 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $7K.
  • Banque Cantonale Vaudoise first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 12 quarters.
  • Banque Cantonale Vaudoise's Orchard Therapeutics plc American Depositary Shares position peaked at $81K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.